Shana Kelley

Shana Kelley is a Professor in the Department of Chemistry at Northwestern University. Her research focuses on the development of biomolecular sensors, phenotypic screening platforms, and molecular delivery vectors using multidisciplinary approaches. She employs cutting-edge techniques such as CRISPR screening and cellular engineering to advance biomedicine. Kelley is affiliated with several institutes, including the Chemistry of Life Processes Institute and the Lurie Cancer Center. Her group has generated over 200 publications and started three companies based on technologies developed in the group. She is also the President of the Chan Zuckerberg Biohub Chicago and holds the Neena B. Schwartz Professorship of Chemistry and Biomedical Engineering.

Shana Kelley is a bioanalytical chemist at Northwestern University, focusing on the development of electrochemical methods for analyzing clinically relevant biomolecules and advancing CO2 reduction technologies. Her research explores electron transfer mechanisms in DNA, including single-base mismatch detection and long-range electron transfer through DNA films. Kelley's work also investigates catalyst synthesis under CO2 electroreduction, aiming to enhance renewable fuel electrosynthesis. Additionally, she examines the use of cell-penetrating peptides for medical applications and the role of metal–organic frameworks in selective CO2 electroreduction. Her research bridges analytical chemistry, electrochemistry, and bioanalytical applications.